Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chennai Meenakshi Multispeciality Hospital (BOM:523489) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Chennai Meenakshi Multispeciality Hospital EBITDA Margin % Related Terms
Chennai Meenakshi Multispeciality Hospital EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chennai Meenakshi Multispeciality Hospital EBITDA Margin % Chart
Chennai Meenakshi Multispeciality Hospital Annual Data
BOM:523489 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Chennai Meenakshi Multispeciality Hospital's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chennai Meenakshi Multispeciality Hospital EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chennai Meenakshi Multispeciality Hospital's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Chennai Meenakshi Multispeciality Hospital's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chennai Meenakshi Multispeciality Hospital (BOM:523489) has a EBITDA Margin % of 4.92% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chennai Meenakshi Multispeciality Hospital and its competitors. This is 34% below median its historical median of 7.49. Over the past decade, Chennai Meenakshi Multispeciality Hospital's EBITDA Margin % has ranged from 1.86 to 18.91. According to the industry distribution chart, Chennai Meenakshi Multispeciality Hospital ranks #469 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 70.8%.
Is Chennai Meenakshi Multispeciality Hospital's EBITDA Margin % too high?
Chennai Meenakshi Multispeciality Hospital's current EBITDA Margin % of 4.92% is 34% below median its 10-year median of 7.49. Over the past 10 years, this metric has ranged from a low of 1.86 to a high of 18.91. The Healthcare Providers & Services industry median EBITDA Margin % is 10.25. Chennai Meenakshi Multispeciality Hospital's value of 4.92% is 52% below this industry median. Based on the distribution chart, Chennai Meenakshi Multispeciality Hospital ranks #469 out of 662 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Chennai Meenakshi Multispeciality Hospital has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chennai Meenakshi Multispeciality Hospital's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Chennai Meenakshi Multispeciality Hospital ranks #469 out of 662 companies for EBITDA Margin %. This places Chennai Meenakshi Multispeciality Hospital in the lower half of its industry. The industry median EBITDA Margin % is 10.25. Chennai Meenakshi Multispeciality Hospital's value of 4.92% is 52% below this benchmark. Historically, Chennai Meenakshi Multispeciality Hospital's own EBITDA Margin % has ranged from 1.86 to 18.91 over the past decade. While the company's 10-year median is 7.49 vs. the industry median of 10.25, Chennai Meenakshi Multispeciality Hospital has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.25, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chennai Meenakshi Multispeciality Hospital's current EBITDA Margin % of 4.92% is 52% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chennai Meenakshi Multispeciality Hospital and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chennai Meenakshi Multispeciality Hospital's current EBITDA Margin % is 4.92%, which is 34% below median its own 10-year median of 7.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chennai Meenakshi Multispeciality Hospital stock overvalued right now?
Based on GuruFocus' analysis, Chennai Meenakshi Multispeciality Hospital (BOM:523489) is currently considered Fairly Valued. The stock's GF Value™ is ₹36.11, compared to a current price of ₹37.30 — trading 3.3% above its estimated fair value. The current EBITDA Margin % is 4.92%, which is 34% below median its 10-year median of 7.49 and 52% below the Healthcare Providers & Services industry median of 10.25. Chennai Meenakshi Multispeciality Hospital's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Chennai Meenakshi Multispeciality Hospital (BOM:523489), the current EBITDA Margin % is 4.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chennai Meenakshi Multispeciality Hospital (BOM:523489) Overvalued in 2026?
Based on GuruFocus' analysis, Chennai Meenakshi Multispeciality Hospital stock appears to be overvalued.
The current stock price of ₹37.30 is trading 3.3% above its estimated GF Value™ of ₹36.11.
GuruFocus considers Chennai Meenakshi Multispeciality Hospital to be Fairly Valued.
Key valuation signals for BOM:523489:
EBITDA Margin %: 4.92% (34% below median its 10-year median of 7.49)
GF Value™: ₹36.11 vs. price of ₹37.30 (3.3% above fair value)
Industry Position: 52% below the Healthcare Providers & Services median (#469 of 662)
No single metric tells the full story. See the BOM:523489 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chennai Meenakshi Multispeciality Hospital Business Description
Chennai Meenakshi Multispeciality Hospital Ltd is an India-based company engaged in hospital activities. It provides healthcare for the society in various branches of medicine, such as General Surgery, General Medicine, Pediatrics, Neurology, Cardiology, ENT, Ophthalmology, Radiology, Pathology, Gastroenterology, Urology, Thoracic Surgery, Plastic Surgery, Orthopedics, and other allied specialties.
63GF Score
Get the complete analysis for BOM:523489
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:523489 has been successfully added to your 
